CFTR modulator use and risk of nontuberculous mycobacteria positivity in cystic fibrosis, 2011–2018

BACKGROUND: People with cystic fibrosis are at increased risk of pulmonary nontuberculous mycobacteria (NTM) disease. Cystic fibrosis transmembrane conductance regulator (CFTR) modulators are associated with reduced lung infection with pathogens like Pseudomonas aeruginosa and Staphylococcus aureus....

Descripción completa

Detalles Bibliográficos
Autores principales: Ricotta, Emily E., Prevots, D. Rebecca, Olivier, Kenneth N.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: European Respiratory Society 2022
Materias:
Original Research Articles
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8995538/
https://www.ncbi.nlm.nih.gov/pubmed/35415188
http://dx.doi.org/10.1183/23120541.00724-2021

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8995538/
https://www.ncbi.nlm.nih.gov/pubmed/35415188
http://dx.doi.org/10.1183/23120541.00724-2021

Ejemplares similares